Surgical Closure of Patent Ductus Arteriosus in Infants Weighing Less than 2.5kg

1995 ◽  
Vol 3 (1) ◽  
pp. 13-15
Author(s):  
Somboon Boonkasem ◽  
Boonchob Pongpanich ◽  
Anant Tejavei

Persistent heart failure is a major problem in low birth weight infants with patent ductus arteriosus (PDA). There is a considerable incidence of renal insufficiency and reopening of the ductus after pharmacologic closure. Surgical closure of symptomatic PDA should therefore be indicated to avoid morbidity or mortality from heart failure and renal failure. Between March 1990 and December 1993 there were 33 low birth weight infants who underwent surgical closure of PDA, ranging in age from 5 to 90 days (mean = 25) with 15 males and 18 females (M:F = 1:1.2). The patients were classified into 3 groups: group 1 (< 1000gm) 11 cases, group 2 (1000-1499gm) 10 cases, group 3 (1500-2499gm) 12 cases. The indications for surgical closure of PDA included: persistent heart failure in 28, renal insufficiency in 20, reopening of the ductus after pharmacologic closure in 16 and growth failure in 1. The early mortality was 6% (2/33). Both of them were in group 1: one from necrotizing enterocolitis (NEC), and one from cytomegalovirus (CMV) infection on the 6th and 20th postoperative day respectively. Late death occurred twice: the first case in group 1 from sepsis 35 days postoperatively, and the second in group 2 from pneumonia 3 months after surgery. The causes of late mortality in both cases were not related to surgery. The 29 survivors are doing reasonably well during follow-up period.

2021 ◽  
pp. 1-5
Author(s):  
Salem Deraz ◽  
Mohamed Tawfik ◽  
Susy Kotit ◽  
Abdelrahman Elafifi

Abstract Introduction: The standard transcatheter technique to profile the patent ductus arteriosus requires arterial access through the femoral artery and is associated with arterial complications, longer fluoroscopic time, contrast volume, and longer hospital stay. Aim of the study: To compare exclusive transvenous access with the standard procedures for patent ductus arteriosus closure and evaluate whether exclusive venous approach is a safe and effective alternative. Methods: A total of 320 patients were included. A detailed echocardiographic evaluation of the duct morphology was performed. Patients were classified into group 1 included patients who underwent exclusive femoral venous access, without any injections of contrast media and group 2 included patients who underwent arterial and venous access. Results: Arterial access was achieved in 210 (65.6%). Successful closure of patent ductus arteriosus was achieved in 109 (99.1%) patients in group 1 and in 203 (96.7%) patients in group 2. The patent ductus arteriosus was large and was referred for surgical closure in one patient from group 1 and 7 patients from group 2. Residual patent ductus arteriosus was seen in 6 cases from group 1 (5.4%) and 12 patients from group 2 (5.7%). None of the cases in group 1 had vascular complications, while vascular complications were seen in 20 cases, all of them in group 2 (9.5%). Nonvascular complications were seen in one patient from group 1 (0.9%) and 15 patients in group 2 (7.1%). The procedure time and fluoroscopy times were less in patients with exclusive transvenous access. Conclusion: Patent ductus arteriosus device closure without arterial access can be accomplished safely and effectively.


2001 ◽  
Vol 17 (5-6) ◽  
pp. 338-341 ◽  
Author(s):  
Harri Niinikoski ◽  
Markku Alanen ◽  
Timo Parvinen ◽  
Riku Aantaa ◽  
Henrik Ekblad ◽  
...  

2018 ◽  
pp. 750-754
Author(s):  
Tomasz Stankowski ◽  
Sleiman Sebastian Aboul-Hassan ◽  
Dirk Fritzsche ◽  
Marcin Misterski ◽  
Jakub Marczak ◽  
...  

2009 ◽  
Vol 4 (1) ◽  
pp. 34-37 ◽  
Author(s):  
Parkash Mandhan ◽  
Stuart Brown ◽  
Askar Kukkady ◽  
Udaya Samarakkody

Sign in / Sign up

Export Citation Format

Share Document